Ask Sterling

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving the EV sector growth?

Structure Therapeutics

Compare Structure Therapeutics…

Clinical-stage biotech. Lead asset aleniglipron: oral small-molecule GLP-1 agonist. Two positive Phase 2 readouts; high-dose 11%+ placebo-adjusted weight loss at 36 weeks. Roche licensing deal ($100M) for additional assets.

$GPCRSouth San Francisco, CA80Biotechnologystructuretx.com

SectorsGLP-1

Mega Chart

All metrics are vertically resized to show how they've changed over time. They're not on the same Y-axis. This chart is meant to compare trends, not values.

3 metrics selected

Stock Price

Income Statement

Balance Sheet

Short-term Investments

Short-term Debt

Long-term Debt

Total Debt

Accounts Receivable

Inventory

Accounts Payable

Cash Flow

Operating Cash Flow

Free Cash Flow

Capital Expenditures

Per Share

Dividend Per Share

Margins

R&D % of Revenue

SG&A % of Revenue

Returns

Return on Equity

Return on Assets

Asset Turnover

Growth

Net Income Growth YoY

EPS Growth YoY

Ratios

Current Ratio

Quick Ratio

Debt-to-Equity

Debt-to-Assets

Interest Coverage

Efficiency

Days Sales Outstanding

Days Inventory Outstanding

Days Payable Outstanding

Macro

Values normalized to 0-100 scale for comparison. Hover for actual values.